BlackRock Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5.56M | Sell |
143,725
-154,804
| -52% | -$5.99M | ﹤0.01% | 1122 |
|
|
2016
Q3 | $15.1M | Sell |
298,529
-53,574
| -15% | -$2.71M | 0.01% | 836 |
|
|
2016
Q2 | $16M | Buy |
352,103
+40,132
| +13% | +$1.82M | 0.01% | 816 |
|
|
2016
Q1 | $12.3M | Sell |
311,971
-46,784
| -13% | -$1.85M | 0.01% | 872 |
|
|
2015
Q4 | $20.3M | Buy |
358,755
+140,356
| +64% | +$7.94M | 0.01% | 774 |
|
|
2015
Q3 | $8.69M | Sell |
218,399
-10,401
| -5% | -$414K | 0.01% | 953 |
|
|
2015
Q2 | $10.9M | Buy |
228,800
+25,044
| +12% | +$1.2M | 0.01% | 938 |
|
|
2015
Q1 | $8.09M | Sell |
203,756
-16,436
| -7% | -$653K | ﹤0.01% | 1011 |
|
|
2014
Q4 | $4.92M | Sell |
220,192
-21,386
| -9% | -$478K | ﹤0.01% | 1129 |
|
|
2014
Q3 | $3.79M | Buy |
241,578
+2,749
| +1% | +$43.1K | ﹤0.01% | 1172 |
|
|
2014
Q2 | $3.54M | Sell |
238,829
-10,107
| -4% | -$150K | ﹤0.01% | 1225 |
|
|
2014
Q1 | $4.01M | Buy |
248,936
+231,830
| +1,355% | +$3.73M | ﹤0.01% | 1186 |
|
|
2013
Q4 | $159K | Sell |
17,106
-18,776
| -52% | -$175K | ﹤0.01% | 2427 |
|
|
2013
Q3 | $406K | Buy |
35,882
+31,476
| +714% | +$356K | ﹤0.01% | 2291 |
|
|
2013
Q2 | $59K | Buy |
+4,406
| New | +$59K | ﹤0.01% | 2408 |
|